Nanoparticles may allow more targeted brain tumor treatment

03/21/2012 | Engineer (U.K.), The

Researchers from the University of Texas Health Science Center used nanoparticles to deliver rhenium-186 directly to brain tumors. The method, which allowed for the agent to remain at the tumor site and limit radiation exposure in healthy tissue while delivering a high dose to the tumor, was successful in animal models, according to the study published in the journal Neuro-Oncology. Researchers hope to start a clinical trial by this summer.

View Full Article in:

Engineer (U.K.), The

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Abbott
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA